Science
Stopping SARS-CoV-2 in its tracks by blocking its main protease – Phys.org
Inasmuch as therapeutic options against coronavirus have been focused mainly on blocking the interaction between its spike protein and the ACE2 receptor on host…
Inasmuch as therapeutic options against coronavirus have been focused mainly on blocking the interaction between its spike protein and the ACE2 receptor on host cells, SARS-CoV-2 has several additional critical proteins that could potentially be targeted with drugs that have already been approved for use against other viruses. One of these viral proteins is the main protease (Mpro) that is needed to separate newly minted polypeptides into their functional component parts.
Scientists from the Department…
-
Business17 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News14 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business18 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business14 hours ago1 ASX dividend stock down 43% I’d buy right now